当前位置：药药网 / 医药文献 /制药提价与抑制仿制药方式(本栏目收费,不能显示细节,电话13136136841)
关键字：
类型：
下载页码(大于1,小于132)：
制药提价与抑制仿制药方式 472条(本栏目收费,不能显示细节,电话13136136841)
boy scout contract clauses, 59,61, 137
59 61 137
Product hopping by Endo and, 78,79
78 79
brand- name drug companies
costs to society of unscrupulous monopoly extensions and patent abuse by, 23
23
efforts of to block generic competition, 9
9
loss of market share after generic drug entry, 7
7
use of clinical trial data of by generic competitors, 22
22
business method patents, 83
83
carve- out requests, 103,104
103 104
carve- outs defined, 103
103
for generic Abilify (antipsychotic,Otsuka), 110,12
110 12
for generic Crestor (AstraZeneca),108,10, 111,12
108 10 111 12
for generic Skelaxin (KingPharmaceuticals), 105,108
105 108
Celgene (pharmaceutical company), 83,84
83 84
Cipro (antibiotic, Bayer) In re Cipro antitrust case, 46,47
46 47
NASDAQ’s Biotechnology Index, 1
1
new chemical entity (NCE) exclusivity, 32
32
Nexium (esomeprazole), 4
4
monopoly profits from, 9
9
product hopping of from Prilosec, 71,74
71 74
Niacor- SR (cholesterol drug, Upsher- Smith), 50
50
subversion of FDA guidelines and, 67
67
Egypt, deal with Gilead, 5,6
5 6
Elements to Assure Safe Use (ETASU), 81,82
81 82
Endo Pharmaceuticals, 94,95
94 95
product hopping via boy scout contract clause by, 78,79
78 79